Australia markets closed

REGN Jan 2025 970.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
83.500.00 (0.00%)
As of 01:24PM EDT. Market open.
Full screen
Previous close83.50
Open83.50
Bid0.00
Ask0.00
Strike970.00
Expiry date2025-01-17
Day's range83.50 - 83.50
Contract rangeN/A
Volume3
Open interest36
  • Investor's Business Daily

    Regeneron Earnings Miss; Biotech Giant's Stock Falls

    Regeneron Pharmaceuticals earnings and sales missed first-quarter estimates early Thursday. Shares fell slightly.

  • GlobeNewswire

    Regeneron Reports First Quarter 2024 Financial and Operating Results

    First quarter 2024 revenues decreased 1% to $3.15 billion versus first quarter 2023; excluding RonapreveTM(a)(b), revenues increased 7%First quarter 2024 Dupixent® global net sales (recorded by Sanofi) increased 24% to $3.08 billion versus first quarter 2023First quarter 2024 U.S. net sales for EYLEA® HD and EYLEA® were $1.40 billion, including $200 million from EYLEA HDFirst quarter 2024 Libtayo® global net sales increased 45% to $264 million versus first quarter 2023First quarter 2024 GAAP dil

  • Zacks

    Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?

    Let's look at five large-cap pharma/biotech companies slated to release quarterly results this week.